The role of miRNA134 in pathogenesis and treatment of intractable epilepsy: a review article

Nucleosides Nucleotides Nucleic Acids. 2024 Mar 26:1-16. doi: 10.1080/15257770.2024.2331046. Online ahead of print.ABSTRACTMicroRNA-134 (miRNA134) has emerged as a critical regulator in the pathogenesis of epilepsy, particularly in intractable cases resistant to conventional therapies. This review explores the multifaceted roles of miRNA134 in epileptogenesis, focusing on its influence on dendritic spine morphology and synaptic plasticity. Through its interactions with proteins such as LIM kinase 1 (LIMK1), Pumilio 2 (PUM2), and Tubby-like protein 1 (TULP1), miRNA134 modulates various molecular pathways implicated in epilepsy development. Preclinical studies have shown pro-mising results in targeting miRNA134 for mitigating seizure activity, highlighting its potential as a therapeutic target. Furthermore, miRNA134 holds promise as a biomarker for epilepsy diagnosis and prognosis, offering opportunities for personalized treatment approaches. However, further research is warranted to elucidate the precise mechanisms underlying miRNA134's effects and to translate these findings into clinical applications.PMID:38531025 | DOI:10.1080/15257770.2024.2331046

Source: Nucleosides, Nucleotides and Nucleic Acids - March 26, 2024 Category: Biochemistry Authors: Maniya Kasaiyan Mohsen Basiri Sara Pajouhanfar Source Type: research